Table 1.

Demographics by OUD Status, Sentinel Admission

Presentation at Sentinel Visit
OUD Only (n = 192)OUD & Meth Use (n = 94)Other (n = 84)OverallOUD Only vs OUD & Meth Usea
Age, y38.0 (31.0–46.0)36.0 (29.0–41.0)41.0 (33.0–51.0)0.0024b0.0473b
Gender, male102 (53.1)55 (58.5)60 (71.4)0.0177c0.3899c
Race<0.0001c0.0371c
 White175 (91.1)93 (98.9)58 (69.0)
 Black or African American12 (6.3)1 (1.1)23 (27.4)
 Other5 (2.6)0 (0.0)3 (3.6)
Insurance plan type0.0029c0.0129c
 Uninsured79 (41.1)56 (59.6)25 (30.5)
 Public72 (37.5)23 (24.5)36 (43.9)
 Private41 (21.4)15 (16.0)21 (25.6)
 Missing022
 Length of stay, d15.5 (7.0–33.5)16.5 (7.0–33.0)10.5 (6.5–20.5)0.1397b
Rural-Urban Continuum Category0.1195d
 Metropolitan148 (77.5)70 (74.5)60 (72.3)
 Micropolitan16 (8.4)11 (11.7)14 (16.9)
 Small Town7 (3.7)2 (2.1)5 (6.0)
 Rural20 (10.5)11 (11.7)4 (4.8)
 Missing101
Hepatitis C test result0.0631c
 Positive60 (65.9)27 (58.7)11 (40.7)
 Negative31 (34.1)19 (41.3)16 (59.3)
 Not tested or NA result1014857
 Meth use indicated, yes0 (0.0)94 (100.0)46 (54.8)
 Addiction medicine consultation, yes185 (96.4)92 (97.9)80 (95.2)0.6286c
 Time to addiction medicine consultation3.0 (1.0–5.0)2.0 (1.0–5.0)4.0 (2.5–6.0)0.0003b0.4633b
 Missing724
Presentation at Sentinel Visit
OUD Only (n = 192)OUD & Meth Use (n = 94)Other (n = 84)OverallOUD Only vs OUD & Meth Usea
Age, y38.0 (31.0–46.0)36.0 (29.0–41.0)41.0 (33.0–51.0)0.0024b0.0473b
Gender, male102 (53.1)55 (58.5)60 (71.4)0.0177c0.3899c
Race<0.0001c0.0371c
 White175 (91.1)93 (98.9)58 (69.0)
 Black or African American12 (6.3)1 (1.1)23 (27.4)
 Other5 (2.6)0 (0.0)3 (3.6)
Insurance plan type0.0029c0.0129c
 Uninsured79 (41.1)56 (59.6)25 (30.5)
 Public72 (37.5)23 (24.5)36 (43.9)
 Private41 (21.4)15 (16.0)21 (25.6)
 Missing022
 Length of stay, d15.5 (7.0–33.5)16.5 (7.0–33.0)10.5 (6.5–20.5)0.1397b
Rural-Urban Continuum Category0.1195d
 Metropolitan148 (77.5)70 (74.5)60 (72.3)
 Micropolitan16 (8.4)11 (11.7)14 (16.9)
 Small Town7 (3.7)2 (2.1)5 (6.0)
 Rural20 (10.5)11 (11.7)4 (4.8)
 Missing101
Hepatitis C test result0.0631c
 Positive60 (65.9)27 (58.7)11 (40.7)
 Negative31 (34.1)19 (41.3)16 (59.3)
 Not tested or NA result1014857
 Meth use indicated, yes0 (0.0)94 (100.0)46 (54.8)
 Addiction medicine consultation, yes185 (96.4)92 (97.9)80 (95.2)0.6286c
 Time to addiction medicine consultation3.0 (1.0–5.0)2.0 (1.0–5.0)4.0 (2.5–6.0)0.0003b0.4633b
 Missing724

Table statistics are reported as median (IQR) for continuous factors and frequency (column percentage) for categorical factors. Missing data are reported and not included in summary statistics, and column totals may be >100% due to rounding. Bold formatting indicates a significant P value at the .05 level.

Abbreviations: IQR, interquartile range; OUD, opioid use disorder.

a

Stated statistical tests are unadjusted and compare only those who have indicated OUD at sentinel hospital visit.

b

Kruskal-Wallis P value.

c

Pearson chi-square P value.

d

Mantel-Haenszel row mean scores P value.

Table 1.

Demographics by OUD Status, Sentinel Admission

Presentation at Sentinel Visit
OUD Only (n = 192)OUD & Meth Use (n = 94)Other (n = 84)OverallOUD Only vs OUD & Meth Usea
Age, y38.0 (31.0–46.0)36.0 (29.0–41.0)41.0 (33.0–51.0)0.0024b0.0473b
Gender, male102 (53.1)55 (58.5)60 (71.4)0.0177c0.3899c
Race<0.0001c0.0371c
 White175 (91.1)93 (98.9)58 (69.0)
 Black or African American12 (6.3)1 (1.1)23 (27.4)
 Other5 (2.6)0 (0.0)3 (3.6)
Insurance plan type0.0029c0.0129c
 Uninsured79 (41.1)56 (59.6)25 (30.5)
 Public72 (37.5)23 (24.5)36 (43.9)
 Private41 (21.4)15 (16.0)21 (25.6)
 Missing022
 Length of stay, d15.5 (7.0–33.5)16.5 (7.0–33.0)10.5 (6.5–20.5)0.1397b
Rural-Urban Continuum Category0.1195d
 Metropolitan148 (77.5)70 (74.5)60 (72.3)
 Micropolitan16 (8.4)11 (11.7)14 (16.9)
 Small Town7 (3.7)2 (2.1)5 (6.0)
 Rural20 (10.5)11 (11.7)4 (4.8)
 Missing101
Hepatitis C test result0.0631c
 Positive60 (65.9)27 (58.7)11 (40.7)
 Negative31 (34.1)19 (41.3)16 (59.3)
 Not tested or NA result1014857
 Meth use indicated, yes0 (0.0)94 (100.0)46 (54.8)
 Addiction medicine consultation, yes185 (96.4)92 (97.9)80 (95.2)0.6286c
 Time to addiction medicine consultation3.0 (1.0–5.0)2.0 (1.0–5.0)4.0 (2.5–6.0)0.0003b0.4633b
 Missing724
Presentation at Sentinel Visit
OUD Only (n = 192)OUD & Meth Use (n = 94)Other (n = 84)OverallOUD Only vs OUD & Meth Usea
Age, y38.0 (31.0–46.0)36.0 (29.0–41.0)41.0 (33.0–51.0)0.0024b0.0473b
Gender, male102 (53.1)55 (58.5)60 (71.4)0.0177c0.3899c
Race<0.0001c0.0371c
 White175 (91.1)93 (98.9)58 (69.0)
 Black or African American12 (6.3)1 (1.1)23 (27.4)
 Other5 (2.6)0 (0.0)3 (3.6)
Insurance plan type0.0029c0.0129c
 Uninsured79 (41.1)56 (59.6)25 (30.5)
 Public72 (37.5)23 (24.5)36 (43.9)
 Private41 (21.4)15 (16.0)21 (25.6)
 Missing022
 Length of stay, d15.5 (7.0–33.5)16.5 (7.0–33.0)10.5 (6.5–20.5)0.1397b
Rural-Urban Continuum Category0.1195d
 Metropolitan148 (77.5)70 (74.5)60 (72.3)
 Micropolitan16 (8.4)11 (11.7)14 (16.9)
 Small Town7 (3.7)2 (2.1)5 (6.0)
 Rural20 (10.5)11 (11.7)4 (4.8)
 Missing101
Hepatitis C test result0.0631c
 Positive60 (65.9)27 (58.7)11 (40.7)
 Negative31 (34.1)19 (41.3)16 (59.3)
 Not tested or NA result1014857
 Meth use indicated, yes0 (0.0)94 (100.0)46 (54.8)
 Addiction medicine consultation, yes185 (96.4)92 (97.9)80 (95.2)0.6286c
 Time to addiction medicine consultation3.0 (1.0–5.0)2.0 (1.0–5.0)4.0 (2.5–6.0)0.0003b0.4633b
 Missing724

Table statistics are reported as median (IQR) for continuous factors and frequency (column percentage) for categorical factors. Missing data are reported and not included in summary statistics, and column totals may be >100% due to rounding. Bold formatting indicates a significant P value at the .05 level.

Abbreviations: IQR, interquartile range; OUD, opioid use disorder.

a

Stated statistical tests are unadjusted and compare only those who have indicated OUD at sentinel hospital visit.

b

Kruskal-Wallis P value.

c

Pearson chi-square P value.

d

Mantel-Haenszel row mean scores P value.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close